Comparing follow-up scan schedules after retroperitoneal sarcoma surgery
Part of Cancer clinical trials.
This trial compares two schedules of follow-up imaging (high vs lower intensity) for people who have had surgery for retroperitoneal sarcoma, to see which is better at detecting recurrence without excessive scans.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You had surgery to remove the entire sarcoma (the first time you had surgery for this cancer)
- Your sarcoma is located in the retroperitoneum (back of the belly), abdomen, or pelvis
- Your surgery was R0 or R1 (meaning the surgeon removed all visible cancer, even if some cancer cells might be left under the microscope)
- You do not have cancer that has spread to other organs (metastatic disease)
- Your scans 3–4 months after surgery did not show any new or remaining cancer
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows adults who have had surgery for a retroperitoneal sarcoma. It collects clinical and imaging information after treatment to better understand outcomes and guide future care.
This trial compares two schedules of post-treatment check-ups to see which one better supports patient quality of life. You’d fill out surveys for up to two years to measure how you feel over time.
This study tests whether a short course of radiation before surgery can treat retroperitoneal sarcoma (a rare cancer in the back of the belly). It is for people whose tumor is removable and who have not had previous radiation in the same area.
This trial compares CT scans to chest X-rays to monitor for lung cancer spread after surgery to remove soft tissue sarcoma. If you are at high risk of the sarcoma returning in your lungs, this study helps see which imaging method works better.
This trial tests a new way of giving radiation called proton spatially fractionated radiotherapy (P-SFRT) combined with standard radiation for people with a type of sarcoma in the back of the belly. The goal is to see if this combination can treat the tumor more effectively.
This trial tests a new approach for people with a rare type of cancer called retroperitoneal sarcoma, which grows in the back of the belly. It combines a short course of radiation and an immunotherapy drug before surgery, aiming to shrink the tumor and improve the chances of successful removal.
Hear when a new Sarcoma,Soft Tissue trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.